Monday, October 15, 2012

Possible Meningitis Infection Linked to Second Product, FDA Says


By Anna Edney on October 15, 2012
A second product manufactured by New England Compounding Center has been linked to another potential meningitis infection, the U.S. Food and Drug Administration said today.
A steriod injection used for back pain from the Framingham, Massachusetts-based pharmacy previously has been tied to an outbreak of 205 reported cases of fungal meningitis in 14 U.S. states, killing 15 people, according to the Centers for Disease Control and Prevention.
To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net
To contact the editor responsible for this story: Andrew Pollack at apollack1@bloomberg.net

Source found here

No comments: